Trials / Completed
CompletedNCT00035867
Study of TLK199 HCl Liposomes for Injection in Myelodysplastic Syndrome
Phase 1-2a Study of TLK199 HCl Liposomes for Injection in Myelodysplastic Syndrome
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 65 (planned)
- Sponsor
- Telik · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the safety and efficacy of TLK199 in patients with myelodysplastic syndrome (MDS).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | TLK199 HCl Liposomes for Injection |
Timeline
- Start date
- 2002-04-01
- Completion
- 2007-05-01
- First posted
- 2002-05-07
- Last updated
- 2008-06-03
Locations
9 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00035867. Inclusion in this directory is not an endorsement.